by Biological seed treatment involves treating seeds with biological agents such as bacteria, fungi and other microorganisms that help promote plant growth and protect seeds and seedlings from diseases and pests. Biological seed treatment products boost crop immunity, improve yields and promote plant health without being harmful to humans and the environment like chemical seed treatments.
The global Biological Seed Treatment Market is estimated to be valued at US$ 1186.51 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Biological treatments help boost crop immunity and make them more resistant to pest and disease attacks without using harmful chemicals. They protect seeds from soil-borne diseases and support better germination resulting in improved yields. With sustainability and safety concerns increasing about chemical crop protection methods, biological seed treatment is emerging as a commercially viable natural alternative to chemicals based seed treatment.
SWOT Analysis
Strength: Biological seed treatment provides protection against various pests and diseases without being harmful to the environment or humans. It promotes plant growth and yield.
Weakness: These treatments require specialized equipment for application and have a limited shelf life. Biological products are susceptible to environmental conditions.
Opportunity: Increasing population is raising global food demand. Farmers are looking for sustainable solutions to boost crop productivity. Biological seed treatments help reduce dependence on chemical pesticides.
Threats: Strict regulations and lengthy registration processes pose challenges. Natural biological control agents can develop resistance to pathogen strains over time.
Key Takeaways
The Global Biological Seed Treatment Market Size is expected to witness high growth.
Regional analysis: The biological seed treatment market in North America is currently the largest due to extensive research and development activities in plant biotechnology. Asia Pacific is projected to grow at the fastest pace during the forecast period driven by the large agriculture industry in countries like India and China. Key players are focusing on expanding their presence in these emerging markets.
Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet. These companies are focused on developing innovative and sustainable biological solutions through research collaborations as well as mergers and acquisitions to strengthen their product portfolios.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
